Cross-Linked HA Dermal Filler 21 mg/ml
Cross-Linked HA Dermal Filler 21 mg/ml — Injectable devices in prefilled syringe form, 1 ml, available for private-label manufacture from 1,000 units, produced in Italy. The actives below carry their INCI names and the strength the product information file states, in mg/ml or percent.
| Dosage form | Prefilled syringe |
|---|---|
| Pack | 1 ml |
| Minimum order | 1,000 units |
| Manufactured in | Italy |
| Market status | Choose your market: Iraq · Gulf · EuropeIraq: documents issued on request; Arabic and English on one pack.Gulf: on offer for the Gulf states. The Gulf pageEurope: on offer for European buyers. Details |
| Documents | Certificate of Analysis, Certificate of Origin, Certificate of Conformity, Free Sale Certificate and MSDS — available on request. |
About this formulation
This formulation, Cross-Linked HA Dermal Filler 21 mg/ml, belongs to the Injectable devices range; it is made in Italy for private-label brands from 1,000 units per SKU. The production time is set in our offer for this product. The declared active is Cross-linked hyaluronic acid 21 mg/ml.
The Injectable devices range: Sodium hyaluronate carries this shelf, for the skin and for the joint.
Related formulations
Active ingredients
- Cross-linked hyaluronic acid 21 mg/ml
Market status in detail
Iraq. The documents for this formulation are listed in the table above and issued on request. Arabic and English artwork is drawn on one pack. The Iraq page
Gulf. This product is on offer for the Gulf states. Tell us the country and the quantity, and we answer with the offer and the documents we supply.
Country pages: Saudi Arabia · UAE · Kuwait · Qatar · Oman · Bahrain
Europe. This product is on offer for European buyers. Tell us the country and the quantity, and we answer with the offer and the documents we supply.
Change market: Iraq · Gulf · Europe · All markets
Shipping and document legalisation for your country are calculated separately and stated in the offer.